Gleeve SA
Gleeve reported total assets of 377,263 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Apr 2026).
The score of Gleeve shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +3 % Total assets +2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Gleeve's annual accounts
Filed annual accounts
- Year ended 30 Dec 2025filed on 30 Apr 2026
- Year ended 30 Dec 2024filed on 28 Apr 2025
- Year ended 30 Dec 2023filed on 24 Jun 2024
- Year ended 30 Dec 2022filed on 23 Jun 2023
- Year ended 30 Dec 2021filed on 20 Jun 2022
Gleeve's financial analysis
- Solvency74.0%sector median: 56.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Gleeve
Gleeve's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0426.004.204
- VAT number
- BE0426004204
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 29 Dec 1983
- Registered office
- 9070 Destelbergen
- Latest accounts
- 2025 · filed on 30 Apr 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 2110001)
Gleeve (SA) has been based in Destelbergen since 1983, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net profit of 1,340 € and equity of 279,168 €; its revenue is not published. Its solvency stands at 74.0%, above the median of its sector (56.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Gleeve
Companies in the same business, of comparable size and area, outside its group.
- Foncière de Molenbeek Buying and selling of own real estate Brussels · balance sheet 377,261 €
- Huisartsen Houtem General medical practice activities Sint-Lievens-Houtem · balance sheet 377,292 €
- Dr. Ilse Mertens, nucleaire geneeskunde Medical specialists activities Pajottegem · balance sheet 377,300 €
- Orphimmo Buying and selling of own real estate Woluwe-Saint-Lambert · balance sheet 377,224 €
- van der Vleuten Real Estate Buying and selling of own real estate Marche-en-Famenne · balance sheet 377,218 €
- Picavet Beheer Manufacture of basic pharmaceutical products Schoten · balance sheet 377,326 €
- Docteur Makhlouf Joseph Medical specialists activities Braine-l'Alleud · balance sheet 377,368 €
- Future Compta Spa · balance sheet 377,154 €
Frequently asked questions about Gleeve
What is the revenue of Gleeve?
Gleeve files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Gleeve?
In Belgium, the VAT number is the company number prefixed with BE: BE0426004204 for Gleeve, if the company is VAT-registered. Its company number (CBE) is 0426.004.204.
Where is the registered office of Gleeve?
According to the CBE register, the registered office of Gleeve is in 9070 Destelbergen.
What is the equity of Gleeve?
At the close of the 2025 financial year, the equity of Gleeve amounts to 279,168 €, a solvency of 74.0% of total assets.
Who manages Gleeve?
The register lists 2 active mandates at Gleeve. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Gleeve
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →